查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888806

微型RNA市場規模、佔有率和趨勢分析報告：按產品/服務、應用、最終用途、地區和細分市場預測（2025-2033年）

MicroRNA Market Size, Share & Trends Analysis Report By Products & Services, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

微型RNA市場摘要

2024年全球微型RNA市場規模估計為17.6億美元，預計2033年將達到54.8億美元。

預計從 2025 年到 2033 年，該市場將以 13.64% 的複合年成長率成長。癌症、心血管疾病和神經系統疾病等疾病在全球日益普遍，以及基因組技術的加速發展，是推動市場成長的主要因素。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 市場變數與趨勢

  • 市場趨勢展望
    • 母市場展望
    • 相關及附隨市場展望
  • 市場動態
  • 產業分析工具
    • 波特五力分析
    • PESTEL 分析

第4章 產品與服務業務分析

  • 微型RNA市場：產品與服務波動分析
  • 產品
    • 產品市場估算與預測，2021-2033年
    • 裝置
    • 消耗品
  • 服務
    • 服務市場估算與預測（2021-2033）
    • 按服務類型
    • 檢體

第5章 應用型業務分析

  • 微型RNA市場：應用差異分析
  • 癌症
    • 癌症市場收入估算與預測，2021-2033年
  • 感染疾病
    • 感染疾病市場收入估算與預測，2021-2033年
  • 免疫疾病
    • 免疫疾病市場收入估算與預測，2021-2033年
  • 心血管疾病
    • 心血管疾病市場收入估算與預測，2021-2033年
  • 神經系統疾病
    • 神經系統疾病市場收入估算與預測，2021-2033年
  • 其他
    • 其他市場市場收入估算與預測（2021-2033 年）

第6章 依最終用途進行業務分析

  • 微型RNA市場：最終用途差異分析
  • 生物技術和製藥公司
    • 生物技術和製藥市場收入估算和預測（2021-2033）
  • 學術和政府研究機構
    • 學術與政府研究機構市場收入估算與預測（2021-2033 年）
  • 其他最終用戶
    • 其他終端用戶市場的市場收入估算與預測（2021-2033 年）

第7章：區域商業分析

  • 按地區分類的微型RNA市場佔有率（2024年和2033年）
  • 北美洲
    • 2021-2033年北美微型RNA市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲微型RNA市場，2021-2033年
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區微型RNA市場，2021-2033年
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2021-2033年拉丁美洲微型RNA市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2021-2033年中東及非洲微型RNA市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 公司分類
  • 策略規劃
  • 企業市場分析（2024）
  • 公司簡介/列表
    • Thermo Fisher Scientific
    • QIAGEN
    • Horizon Discovery Group plc.
    • Merck KGaA
    • Takara Bio, Inc.
    • LGC Limited
    • BioGenex
    • GeneCopoeia, Inc.
    • New England Biolabs
    • NanoString Technologies, Inc.
Product Code: GVR-2-68038-368-3

MicroRNA Market Summary

The global microRNA market size was estimated at USD 1.76 billion in 2024 and is projected to reach USD 5.48 billion by 2033, growing at a CAGR of 13.64% from 2025 to 2033. The increasing prevalence of diseases such as cancer, cardiovascular diseases, and neurological disorders across the globe, as well as growing advancements in genomic technologies, are the prime factors that drive market growth.

Global MicroRNA Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global microRNA market on the basis of product & service, application, end-use, and region:

  • Product & Services Outlook (Revenue in USD Million, 2021- 2033)
  • Services
    • Type
    • Isolation & Purification
    • miRNA cDNA Synthesis
    • Profiling, Localization, & Quantification
    • Functional Analysis
    • Others
    • Specimen
    • Whole Blood
    • Serum
    • Plasma
    • FFPE
    • Fresh Frozen Tissue
    • Others
  • Products
    • Instruments
    • Technology
    • Real Time PCR
    • Microarray
    • NGS
    • Others
    • Workflow
    • Isolation & Purification
    • miRNA cDNA Synthesis
    • Profiling, Localization, & Quantification
    • Functional Analysis & Others
    • Others
    • Consumables
    • Specimens
    • Whole Blood
    • Serum
    • Plasma
    • FFPE
    • Fresh Frozen Tissue
    • Others
    • Workflow
    • Isolation & Purification
    • miRNA cDNA Synthesis
    • Profiling, Localization, & Quantification
    • Functional Analysis
    • Others
  • Application Outlook (Revenue, USD Million, 2021- 2033)
  • Cancer
  • Infectious Diseases
  • Immunological Disorder
  • Cardiovascular Disease
  • Neurological Disease
  • Others
  • End-use Outlook (Revenue, USD Million; 2021 - 2033)
  • Biotechnology & Pharmaceutical Companies
  • Academic & Government Research Institutes
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • U.K
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objective
    • 1.4.1. Objective 1
    • 1.4.2. Objective2
    • 1.4.3. Objective 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis:
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables and Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Expanding use of miRNA in drug development & therapeutics
      • 3.2.1.2. Increasing cancer prevalence and need for early-stage diagnostics
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with microRNA kits and other products
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Product & Service Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. MicroRNA Market: Product & Service Movement Analysis
  • 4.3. Product
    • 4.3.1. Product Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Instruments
      • 4.3.2.1. Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.2. By Technology
        • 4.3.2.2.1. Real-Time PCR
          • 4.3.2.2.1.1. Real-Time PCR Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.2.2. Microarray
          • 4.3.2.2.2.1. Microarray Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.2.3. NGS
          • 4.3.2.2.3.1. NGS Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.2.4. Others
          • 4.3.2.2.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.3. By Workflow
        • 4.3.2.3.1. Isolation & Purification
          • 4.3.2.3.1.1. Isolation & Purification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.3.2. miRNA cDNA Synthesis
          • 4.3.2.3.2.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.3.3. Profiling, Localization, & Qualification
          • 4.3.2.3.3.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.3.4. Functional Analysis & Others
          • 4.3.2.3.4.1. Functional Analysis & Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.3.5. Others
          • 4.3.2.3.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Consumables
      • 4.3.3.1. Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.2. By Specimen
        • 4.3.3.2.1. Whole Blood
          • 4.3.3.2.1.1. Whole Blood Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.3.3.2.2. Serum
          • 4.3.3.2.2.1. Serum Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.3.3.2.3. Plasma
          • 4.3.3.2.3.1. Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.3.3.2.4. FFPE
          • 4.3.3.2.4.1. FFPE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.3.3.2.5. Fresh Frozen Tissue
          • 4.3.3.2.5.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.3.3.2.6. Others
          • 4.3.3.2.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.3. By Workflow
        • 4.3.3.3.1. Isolation & Purification
          • 4.3.3.3.1.1. Isolation & Purification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.3.3.3.2. miRNA cDNA Synthesis
          • 4.3.3.3.2.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.3.3.3.3. Profiling, Localization, & Qualification
          • 4.3.3.3.3.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.3.3.3.4. Functional Analysis & Others
          • 4.3.3.3.4.1. Functional Analysis & Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.3.3.3.5. Others
          • 4.3.3.3.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Services
    • 4.4.1. Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. By Service Type
      • 4.4.2.1. Isolation & Purification
        • 4.4.2.1.1. Isolation & Purification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.2. miRNA cDNA Synthesis
        • 4.4.2.2.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.3. Profiling, Localization, & Qualification
        • 4.4.2.3.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.4. Functional Analysis
        • 4.4.2.4.1. Functional Analysis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.5. Others
        • 4.4.2.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. By Specimen
      • 4.4.3.1. Whole Blood
        • 4.4.3.1.1. Whole Blood Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2. Serum
        • 4.4.3.2.1. Serum Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.3. Plasma
        • 4.4.3.3.1. Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.4. FFPE
        • 4.4.3.4.1. FFPE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.5. Fresh Frozen Tissue
        • 4.4.3.5.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.6. Others
        • 4.4.3.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. MicroRNA Market: Application Movement Analysis
  • 5.3. Cancer
    • 5.3.1. Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Infectious Diseases
    • 5.4.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Immunological Disorder
    • 5.5.1. Immunological Disorder Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Cardiovascular Disease
    • 5.6.1. Cardiovascular Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Neurological Disease
    • 5.7.1. Neurological Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. MicroRNA Market: End Use Movement Analysis
  • 6.3. Biotechnology & Pharmaceutical Companies
    • 6.3.1. Biotechnology & Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Academic & Government Research Institutes
    • 6.4.1. Academic & Government Research Institutes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Other End-users
    • 6.5.1. Other End-users Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. MicroRNA Market Share By Region, 2024 & 2033
  • 7.2. North America
    • 7.2.1. North America MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Regulatory framework
      • 7.2.2.3. Competitive Scenario
      • 7.2.2.4. U.S. MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Regulatory framework
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Canada MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Regulatory framework
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Mexico MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. UK MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Regulatory framework
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Germany MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Regulatory framework
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. France MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Regulatory framework
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Italy MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Regulatory framework
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Spain MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Regulatory framework
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Denmark MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Regulatory framework
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Sweden MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Regulatory framework
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Norway MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Japan MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. China MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. India MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Regulatory framework
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Australia MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Regulatory framework
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Thailand MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Regulatory framework
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. South Korea MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Brazil MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Argentina MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. South Africa MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Saudi Arabia MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. UAE MicroRNA Market, 2021 - 2033 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Kuwait MicroRNA Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. QIAGEN
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Horizon Discovery Group plc.
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Merck KGaA
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Takara Bio, Inc.
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. LGC Limited
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. BioGenex
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. GeneCopoeia, Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. New England Biolabs
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. NanoString Technologies, Inc.
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 4 Global MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 5 Global MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 6 Global MicroRNA Market, by Region, 2021 - 2033 (USD Million)
  • Table 7 North America MicroRNA Market, by Country, 2021 - 2033 (USD Million)
  • Table 8 North America MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 9 North America MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 10 North America MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 11 U.S. MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 12 U.S. MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 13 U.S. MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 14 Canada MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 15 Canada MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 16 Canada MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 17 Mexico MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 18 Mexico MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 19 Mexico MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 20 Europe MicroRNA Market, by Country, 2021 - 2033 (USD Million)
  • Table 21 Europe MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 22 Europe MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 23 Europe MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 24 Germany MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 25 Germany MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 26 Germany MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 27 UK MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 28 UK MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 29 UK MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 30 France MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 31 France MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 32 France MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 33 Italy MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 34 Italy MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 35 Italy MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 36 Spain MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 37 Spain MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 38 Spain MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 39 Denmark MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 40 Denmark MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 41 Denmark MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 42 Norway MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 43 Norway MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 44 Norway MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 45 Sweden MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 46 Sweden MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 47 Sweden MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific MicroRNA Market, by Country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 52 Asia Pacific MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 53 China MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 54 China MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 55 China MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 56 Japan MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 57 Japan MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 58 Japan MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 59 India MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 60 India MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 61 India MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 62 South Korea MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 63 South Korea MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 64 South Korea MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 65 Australia MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 66 Australia MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 67 Australia MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 68 Thailand MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 69 Thailand MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 70 Thailand MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 71 Latin America MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 72 Latin America MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 73 Latin America MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 74 Brazil MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 75 Brazil MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 76 Brazil MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 77 Argentina MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 78 Argentina MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 79 Argentina MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa MicroRNA Market, by Country, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 83 Middle East & Africa MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 84 South Africa MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 85 South Africa MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 86 South Africa MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 90 UAE MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 91 UAE MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 92 UAE MicroRNA Market, End-user, 2021 - 2033 (USD Million)
  • Table 93 Kuwait MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 94 Kuwait MicroRNA Market, by Application, 2021 - 2033 (USD Million)
  • Table 95 Kuwait MicroRNA Market, End-user, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 MicroRNA market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Market trends & outlook
  • Fig. 16 PESTEL analysis
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 MicroRNA market: Product & services outlook & key takeaways
  • Fig. 19 MicroRNA market: Product & services movement analysis
  • Fig. 20 Products Market, 2021 - 2033 (USD million)
  • Fig. 21 MicroRNA market: by product type
  • Fig. 22 Instruments Market, 2021 - 2033 (USD million)
  • Fig. 23 MicroRNA market: by technology
  • Fig. 24 Real Time PCR Market, 2021 - 2033 (USD million)
  • Fig. 25 Microarray Market, 2021 - 2033 (USD million)
  • Fig. 26 NGS Market, 2021 - 2033 (USD million)
  • Fig. 27 Others Market, 2021 - 2033 (USD million)
  • Fig. 28 MicroRNA market: by workflow
  • Fig. 29 Isolation & Purification Market, 2021 - 2033 (USD million)
  • Fig. 30 miRNA cDNA Synthesis Market, 2021 - 2033 (USD million)
  • Fig. 31 Profiling, Localization, & Quantification Market, 2021 - 2033 (USD million)
  • Fig. 32 Functional Analysis & Others Market, 2021 - 2033 (USD million)
  • Fig. 33 Others Market, 2021 - 2033 (USD million)
  • Fig. 34 Consumables Market, 2021 - 2033 (USD million)
  • Fig. 35 MicroRNA market: by specimen
  • Fig. 36 Whole Blood Market, 2021 - 2033 (USD million)
  • Fig. 37 Serum Market, 2021 - 2033 (USD million)
  • Fig. 38 Plasma Market, 2021 - 2033 (USD million)
  • Fig. 39 FFPE Market, 2021 - 2033 (USD million)
  • Fig. 40 Fresh Frozen Tissue Market, 2021 - 2033 (USD million)
  • Fig. 41 Others Market, 2021 - 2033 (USD million)
  • Fig. 42 MicroRNA market: by workflow
  • Fig. 43 Isolation & Purification Market, 2021 - 2033 (USD million)
  • Fig. 44 miRNA cDNA Synthesis Market, 2021 - 2033 (USD million)
  • Fig. 45 Profiling, Localization, & Quantification Market, 2021 - 2033 (USD million)
  • Fig. 46 Functional Analysis Market, 2021 - 2033 (USD million)
  • Fig. 47 Others Market, 2021 - 2033 (USD million)
  • Fig. 48 Services Market, 2021 - 2033 (USD million)
  • Fig. 49 MicroRNA market: by services type
  • Fig. 50 Isolation & Purification Market, 2021 - 2033 (USD million)
  • Fig. 51 miRNA cDNA Synthesis Market, 2021 - 2033 (USD million)
  • Fig. 52 Profiling, Localization, & Quantification Market, 2021 - 2033 (USD million)
  • Fig. 53 Functional Analysis Market, 2021 - 2033 (USD million)
  • Fig. 54 Others Market, 2021 - 2033 (USD million)
  • Fig. 55 MicroRNA market: specimen
  • Fig. 56 Whole Blood Market, 2021 - 2033 (USD million)
  • Fig. 57 Serum Market, 2021 - 2033 (USD million)
  • Fig. 58 Plasma Market, 2021 - 2033 (USD million)
  • Fig. 59 FFPE Market, 2021 - 2033 (USD million)
  • Fig. 60 Fresh Frozen Tissue Market, 2021 - 2033 (USD million)
  • Fig. 61 Others Market, 2021 - 2033 (USD million)
  • Fig. 62 MicroRNA market: Application outlook key takeaways
  • Fig. 63 MicroRNA market: Application movement analysis
  • Fig. 64 Cancer Market, 2021 - 2033 (USD million)
  • Fig. 65 Infectious Diseases Market, 2021 - 2033 (USD million)
  • Fig. 66 Immunological Disorder Market, 2021 - 2033 (USD million)
  • Fig. 67 Cardiovascular Disease Market, 2021 - 2033 (USD million)
  • Fig. 68 Neurological Disease Market, 2021 - 2033 (USD million)
  • Fig. 69 Others Market, 2021 - 2033 (USD million)
  • Fig. 70 MicroRNA market: End use outlook key takeaways
  • Fig. 71 MicroRNA market: End use movement analysis
  • Fig. 72 Biotechnology & Pharmaceutical Companies Market, 2021 - 2033 (USD million)
  • Fig. 73 Academic & Government Research Institutes Market, 2021 - 2033 (USD million)
  • Fig. 74 Others Market, 2021 - 2033 (USD million)
  • Fig. 75 Regional outlook
  • Fig. 76 Regional marketplace: Key takeaways
  • Fig. 77 North America microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 78 Key country dynamics
  • Fig. 79 U S microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Canada microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Mexico microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 84 Europe microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Germany microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 87 Key country dynamics
  • Fig. 88 UK microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 89 Key country dynamics
  • Fig. 90 France microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Italy microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Spain microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Denmark microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Sweden microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Norway microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 101 Asia Pacific microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Japan microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 104 Key country dynamics
  • Fig. 105 China microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 106 Key country dynamics
  • Fig. 107 India microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 108 Key country dynamics
  • Fig. 109 Australia microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 110 Key country dynamics
  • Fig. 111 Thailand microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 112 Key country dynamics
  • Fig. 113 South Korea microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 114 Latin America microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 115 Key country dynamics
  • Fig. 116 Brazil microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 117 Key country dynamics
  • Fig. 118 Argentina microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 119 MEA microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 120 Key country dynamics
  • Fig. 121 South Africa microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 122 Key country dynamics
  • Fig. 123 Saudi Arabia microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 124 Key country dynamics
  • Fig. 125 UAE microRNA market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 126 Key country dynamics
  • Fig. 127 Kuwait microRNA market estimates and forecasts, 2021 - 2033 (USD million)